Introduction
Detection of low molecular weight substances is of immense importance for diagnosis of diseases and analytical approaches in food and environmental sciences. A number of small molecules like steroids, thyroid hormones, and peptides derived from disease-specific proteins have been utilized as diagnostic markers in biomedical science for analysis. [1] [2] [3] On the other hand, excess use of pesticides, toxins and drugs are still serious issues in developing countries. The body's physiological activities including various enzymes are directly affected by synthetic drugs and hormone-like pollutants, which also hamper immune function. Moreover, some of these pollutants exercise their adverse effects by disrupting the natural hormone balance of the animals. 4 Therefore, the potential adverse effects of those kinds of toxic composites found in the environment and also in humans are a major concern.
Immunoassays have been studied as a means to detect haptens and peptides and have shown inimitable merits for many years. Immunoassay offers advantages like handiness, simple and fast operation, high specificity and sensitivity, and hence has very broad application prospects over traditional methods such as chromatography and mass spectrometry which need large and costly instruments. 5 Immunodiagnostics can be a simple but very powerful approach once the development of various disease markers and corresponding good antibodies has been achieved.
For the detection of low molecular weight antigens, the most commonly used immunoassay approach is competitive assay, in which either a labeled antigen or labeled antibody is used as a competitor to monitor the amount of antigen in the sample. However, this assay generally needs careful optimization with pre-experiments, and the detectable concentrations are almost always higher than the theoretical expectations. 6 To obviate these limitations, another approach termed open sandwich immunoassay (OS-IA) has been proposed for some time. OS-IA is based on the antigen-dependency of the interaction between the separated heavy chain (VH) and light chain (VL) of an antibody variable region as a detection principle. 7 In the absence of antigen, many of the two V region fragments are prone to dissociate, while in the presence of antigen, these turn to associate by the bridging effect of antigen. It has been established that OS-IA is a promising method to measure the concentration of many small molecules in various samples, and it outperforms corresponding competitive assays in terms of sensitivity, working range and assay time/handlings. ELISA 12 and so on. To improve the sensitivity of OS-IA, previously we developed a phage-based OS Immuno-PCR assay that combines the merits of OS-IA and real time PCR. The assay significantly improved the detection sensitivity of OS-ELISA. 13 In the case of phage-based OS Immuno-PCR, the DNA inside filamentous phage displaying antibody fragment was used as a probe for real time PCR. However, phages are stable particles and the extraction efficiency of DNA from phage particles by heating may not be very reproducible. Also, phages should be prepared freshly, which also affects reproducibility and practical utility of the assay. To obviate all of these limitations, in this study we attempted streptavidin (SA)-based OS Immuno-PCR system for the sensitive detection of a fragmented peptide of a bone-related disease marker osteocalcin (BGP-C7) (Fig. 1A) .
Bone Gla protein (BGP) is known as a marker for bone metabolism and also suspected for its roles in insulin regulation 14 and male fertility. 15 So far, Lim et al. developed a practical OS ELISA to detect C-terminal peptide of BGP with the antibody KTM219, which showed higher sensitivity than the corresponding competitive ELISA. 16 Furthermore, an affinitymatured antibody O2AG2 with higher affinity than KTM219 was made by Iwai et al. through a phage-based method. 17 In this study, fragments of these antibodies were used for the detection of BGP-C7.
Experimental

Materials
BGP-C7 peptide (NH2-RRFYGPV-COOH) and oligonucleotides were synthesized by Genscript (Piscataway, NJ) and Fasmac (Kanagawa, Japan), respectively.
The sequences of oligonucleotides used in this study are shown in Table S1 (Supporting Information). Escherichia coli strains used in this study were XL10-Gold (Stratagene, La Jolla, CA) for general cloning, BL21 (DE3, pLysS) (Novagen, San Diego, CA), SHuffle Express, and SHuffle T7 Express lysY (NEB, Ipswich, MA) for expressing soluble proteins. SsoAdvanced TM SYBR ® Green Supermix (Bio-Rad, Tokyo, Japan) was employed in real-time PCR. Restriction and modification enzymes were purchased from Takara-Bio (Shiga, Japan), Toyobo Biochemicals (Osaka, Japan), Roche Diagnostics (Tokyo, Japan), or New England Biolabs (Ipswich, MA). Other chemicals, reagents, and antibodies, unless otherwise indicated, were obtained from Sigma (St. Louis, MO) or Wako Pure Chemicals (Osaka, Japan). The composition of media and buffers used are listed in Table S2 (Supporting Information). 
Expression and purification of fusion proteins
To express the fusion protein of streptavidin (SA) and VL derived of anti-osteocalcin antibody KTM219, the gene for VL was used to replace the scFv gene of pET-SA-scFv. First, pET-SA-scFv was made by inserting the SA-scFv gene to pET20b(+). The SA gene was amplified from the plasmid pColdII-SA that encodes the gene for wild-type SA (a.a. 39 -183) between EcoRI and XbaI sites of pColdII vector (Takara-Bio), with the primers SA_EcoRVback and SA_linkFor. The scFv gene was amplified from our stock using the primers LinkSfiBack and Jk1NotFor. After making the SA-scFv gene by splice overlap extension PCR, the insert and pET20b(+) vector genes were digested with restriction enzymes EcoRV and NotI, and purified. The purified fragments were ligated using Ligation High Ver. 2 (Toyobo) to obtain pET-SA-scFv. The VL gene was amplified by PCR using the plasmid pMAL-VL (KTM219) as a template, 12 and the primers VL219NcoSalBack and T7term. This insert and pET-SA-scFv were digested with restriction enzymes NcoI and NotI, and ligated to give pET-SA-VL (KTM219) (Fig. 1B) . E. coli BL21 (DE3, pLysS) cells were transformed with the plasmid and cultured in 1.6 L LBAC medium. The expressed SA-VL fusion protein was purified using Talon immobilized metal affinity resin (Clontech, Takara-Bio). To confirm the amount and purity of the protein, 10 microliters of the samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and stained with a Quick-CBB staining kit (Wako). When the purity of SA-VL protein thus made was not good enough, further purification by an anion-exchange chromatography was performed using an Uno-Q1 column on a Biologic Duo-Flow system (Bio-Rad).
Phagemid pIT2-VH (O2AG2), which encodes the VH gene of a higher affinity mutant of KTM219, O2AG2, was previously isolated from a PCR-randomized VH library by open-sandwich selection. 17 The O2AG2 VH gene was amplified and cloned into the SfiI-NotI region of the pET-MBPp-VH (BPA) vector 18 to make pET-MBPp-VH (O2AG2). E. coli BL21 (DE3, pLysS) cells were transformed with this vector and cultured. Intracellular soluble MBP-VH protein was extracted by sonication, and purified similarly to SA-VL. The protein concentration was determined by using a colorimetric assay (Pierce 660 nm Protein Assay, Thermo Scientific).
Plasmid pColdII-SA was used to transform E. coli SHuffle T7 Express to express SA protein, which was used as a positive control in biotin binding assay. The expression and purification was performed similarly except that the expression was induced by placing the culture at 16 C.
Biotin-binding assay
Biotin-binding assay was performed to confirm the function of expressed SA and SA-VL proteins. The wells of a microplate were immobilized with purified SA, SA-VL, and bovine serum albumin (BSA) (5 μg/mL each in PBS), and incubated at 4 C for 16 h. After washing with PBS containing 0.1% Tween 20 (PBST), the wells were blocked with 20% (v/v) Immunoblock (DS Pharma, Osaka, Japan) in PBS (20% IPBS) for 2 h at 25 C and washed with PBST. One μg/mL of biotinylated horseradish peroxidase (Biotin-HRP; Thermo Scientific) in 20% IPBS was added, and incubated for 30 min at 25 C. The well was washed three times with PBST, and 100 μL substrate solution (100 μg/mL 3,3′,5,5′-tetramethylbenzidine (Sigma) and 0.04 μL/mL H2O2 in 100 mM sodium acetate, pH 6.0) was added for color development. After stopping the reaction by adding 50 μL 10% (v/v) H2SO4, the absorbance at 450 nm was read with a Model 680 microplate reader (Bio-Rad).
OS-ELISA
To confirm the functional integrity of MBP-VH and SA-VL, OS-ELISA was carried out. In brief, MBP-VH protein (3 μg/mL in PBS) was immobilized to the wells of an ELISA plate (MS-7296F, Sumitomo Bakelite, Tokyo, Japan) at 4 C for 16 h. After washing with PBST, 20% IPBS was added for blocking and incubated at 2 h at 25 C. After washing with PBST, 3 μg/ mL SA-VL in 5% IPBS was added with or without antigen, and incubated for 1 h at 5 C. After washing with PBST, 1 μg/mL of Biotin-HRP was added, and developed as above.
Preparation of biotinylated DNA
Biotinylated DNA was amplified by using pBluescript KSII+ plasmid as a template with primers M13RV and bio-pBS_PvuII, which was biotinylated at its 5′ end. KOD plus polymerase (Toyobo, Osaka, Japan) was used to amplify the 320 bp DNA containing a PvuII restriction site near the biotinylated terminus. Reaction condition of PCR is 94 C for 2 min, 94 C for 15 s and 45 C for 1 min in 30 cycles. The amplified PCR products were purified by a Wizard SV gel and clean up system (Promega, Madison, WI).
OS Immuno-PCR
First, 100 μL of MBP-VH (1.5 μg/mL in PBS) was coated to the wells of the ELISA plate at 4 C for 16 h. After washing with PBST, 20% IPBS containing 100 μg/mL of salmon sperm DNA (Wako) was added for blocking for 2 h at 25 C. The purified biotinylated DNA (4.6 μg/mL) and SA-VL protein (3 μg/mL) were preincubated in 5% IPBS for 1 h at 25 C, and after washing the well with PBST, to this mixture (100 μL each) was added varied amounts of antigen, and incubated for 1 h at 25 C. After vigorous washings with PBST and Milli-Q water to remove unbound DNA and non-specific analytes, the bound DNA was digested with restriction enzyme PvuII (2 U) for 2 h at 37 C in the M buffer (Takara-Bio, Shiga, Japan). The eluted DNA (5 μL) was amplified with 200 nM of Q_forward and Q_ reverse primers according to Furuya et al. 19 and SsoFast EvaGreen supermix in a total volume of 10 μL using a MiniOpticon thermal cycler (Bio-Rad) at 95 C for 3 min; 95 C for 10 s; 65 C for 30 s; and 72 C for 1 min for 40 cycles.
Data analysis
The data obtained in OS-ELISA were analyzed using Kaleida Graph (Synergy Software, Reading, PA). The dose-response curves in OS-ELISA were fitted to a four parameter equation.
The limit of detection (LOD) of each assay was obtained as the estimated antigen concentration that shows the mean blank value plus 3 SD.
Results and Discussion
Protein expression
To perform OS immunoassays, tagged variable region (VL and VH) fragments derived of a suitable antibody have to be prepared to conduct the assay. In this case, we decided to use fragments of an anti-BGP antibody and its derivatives as a model because they showed excellent properties in several assays to date. We used the VH fragment tethered with MBP for immobilization, and tethered the VL fragment to SA for the detection. To express SA-VL, we linked the genes for SA and VL by splice-overlap extension PCR, and cloned the fusion gene into pET20b vector to make a plasmid pET-SA-VL. E. coli BL21 (DE3, pLysS) cells were transformed with this plasmid, and cultured to expect secretion of the product with proper folding As expected, the SA-VL fusion protein was found to be expressed in the periplasmic fraction, and was purified by metal affinity resin. Since the amount and purity of the protein was not enough as other bands were also seen in the SDS-PAGE gel, an anion-exchange chromatography was performed to remove other proteins. As shown in the SDS-PAGE (Fig. 1C) , SA-VL was successfully purified as a single band, and used for further analysis and assays.
Similarly, the gene for MBP-VH protein was constructed, in which a high affinity mutant VH gene was employed with an expectation of improved sensitivity ( Fig. 2A) . As with SA-VL, MBP-VH was also found expressed in E. coli periplasm, and was purified by immobilized metal affinity chromatography. The amount and purity of the protein was confirmed by SDS-PAGE as shown in Fig. 2B . The concentration was determined by using colorimetric assay.
On the other hand, His-tagged SA protein was expressed in larger quantity at E. coli cytoplasm as a soluble protein by using pColdII cold shock expression system. The expressed SA protein was purified similarly, and confirmed by SDS-PAGE as shown in Fig. S1 (Supporting Information).
Biotin binding assay
To confirm the functional integrity of SA and its fusion protein SA-VL, the biotin binding activity of SA-VL protein was investigated by biotin binding assay using biotinylated HRP. As shown in Fig. 2C , SA-VL showed sufficiently strong biotin binding activity compared with SA as a positive control. BSA as a negative control did not show detectable binding to biotin-HRP.
Detection of BGP-C7 peptide by OS-ELISA
An OS-ELISA with MBP-VH and SA-VL was performed to detect small molecular weight (967 Da) BGP-C7 peptide in samples. MBP-VH was immobilized onto polystyrene microplate wells, and it would bind SA-VL in the presence of antigen BGP-C7. MBP helps coating of the VH domain to the polystyrene microplate. As a result of OS-ELISA using biotinylated HRP as a label, an increasing signal was obtained according to the antigen concentration, with an LOD of 100 pg/mL of BGP-C7 peptide in the sample (Fig. 3A) .
Detection of BGP C7 peptide by using OS Immuno-PCR
Based on the condition of OS-ELISA, Immuno-PCR was carried out. In the case of Immuno-PCR, biotinylated DNA was used as a label instead of biotin-HRP. Biotinylated DNA was prepared by PCR and confirmed to have a correct size of 320 bp by an agarose gel electrophoresis (Fig. S2 , Supporting Information). Biotinylated DNA and SA-VL protein were preincubated, and the SA-VL-DNA complex together with varied concentrations of BGP-C7 peptide were reacted with immobilized MBP-VH on microplate wells. After incubation for an hour, extensive washing was performed to remove non-specific elements. The bound DNA was released by using PvuII restriction enzyme that is expected to reduce elution of non-specifically bound DNA, and was quantified by a real time PCR.
As a result, in the sample without antigen, in average, 5.62 pg of DNA probably due to non-specific binding and/or DNA amplification or the weak VH/VL interaction, was detected. For the samples with 0.1, 1.0, and 10 pg/mL BGP-C7, 21.43, 32.72, and 44.02 pg of DNA, respectively, were detected. Based on these data, a dose-dependent curve between the concentration of BGP-C7 and the amount of probe DNA was drawn. This SA-based OS Immuno-PCR could detect 100 fg/mL of BGP-C7 peptide as an LOD, which clearly exceeds that of corresponding OS-ELISA (Fig. 3B) .
Conclusions
Since Immuno-PCR is an ultrasensitive method for detecting a trace amount of specific antigen, 21 we attempted to apply this method to OS-IA to improve its sensitivity. Streptavidin fusion protein-based OS Immuno-PCR showed improved sensitivity and practical utility, compared with corresponding OS-ELISA and our previous phage-based OS-IAs. 13 It is worth noting that in our previous phage-based OS-IAs, higher affinity mutant VH(R4A10) displayed on phage was used instead of current VH (O2AG2) tethered to MBP. A possible reason for the improvements is the multi-valent interaction of well-bound MBP-VH and tetravalent SA-VL, which is expected to increase its binding avidity. 22 However, it could also increase the background signal without antigen. By reducing the background signal by extensive washing and specific elution by enzymatic digestion, SA-based OS Immuno-PCR worked with a low LOD of 100 fg/mL (100 fM, 10 amole). Although the performance of immuno-PCR depends on each reaction condition in the microplate wells and PCR tubes, once the system is optimized, OS immuno-PCR will be applied to detect many small antigens with high sensitivity. The most important parameters include streptavidin protein concentration and biotinylated DNA in real time PCR. 19 As a sensitive open sandwich immuno-PCR for small molecules has been established, the approach could be a milestone in various analytical areas including clinical detection of disease biomarkers, and food/environmental monitoring of various toxic compounds.
